FPE3 Stock Analysis: Fuchs Petrolub SE | XETRA
Specialty Chemicals | XETRA, Germany | Market Cap: 5.596m EUR | 12M Return: 14.7% | DE000A3E5D64 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.49M
EPS Trend: 88.3%
Qual. Beats: 1
Rev. Trend: 74.7%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Fuchs SE, headquartered in Mannheim, Germany, is a global manufacturer of specialty lubricants and functional fluids operating across Europe, the Middle East, Africa, Asia Pacific, and the Americas. Founded in 1931, the company (formerly known as Fuchs Petrolub SE, renamed in July 2023) serves a broad customer base spanning the automotive, industrial, engineering, construction, mining, transport, steel and cement, aerospace, wind energy, and food sectors.
The companys product portfolio is organized into several categories: automotive and industrial lubricants (including engine oils, gear oils, hydraulic fluids, and biodegradable options), lubricating greases for applications ranging from roller bearings to rail vehicles, metal processing lubricants (such as cutting, grinding, and forming fluids), and special application products including solid film lubricants, corrosion protection, and release agents. Fuchs also provides open gear and surface coating services.
FPE3 represents the companys preference shares, which are listed on XETRA. As a mid-cap player in the GICS Specialty Chemicals sub-industry, the company benefits from growing global demand for high-performance, application-specific lubricants, particularly in segments driven by industrial automation, renewable energy (notably wind), and increasingly stringent regulatory requirements for environmentally compatible products.
- Base oil and additive costs squeeze specialty lubricant margins
- European industrial slowdown curbs manufacturing lubricant demand
- Automotive OEM weakness pressures volume growth in EMEA
| Net Income: 359.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -5.46 > 1.0 |
| NWC/Revenue: 23.16% < 20% (prev 20.79%; Δ 2.37% < -1%) |
| CFO/TA 0.10 > 3% & CFO 327.0m > Net Income 359.0m |
| Net Debt (23.0m) to EBITDA (638.0m): 0.04 < 3 |
| Current Ratio: 2.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (131.0m) vs 12m ago -0.01% < -2% |
| Gross Margin: 34.49% > 18% (prev 34.67%; Δ -0.18% > 0.5%) |
| Asset Turnover: 138.0% > 50% (prev 134.7%; Δ 3.30% > 0%) |
| Interest Coverage Ratio: 48.91 > 6 (EBIT TTM 538.0m / Interest Expense TTM 11.0m) |
| A: 0.29 (Total Current Assets 1.77b - Total Current Liabilities 847.0m) / Total Assets 3.14b |
| B: 0.09 (Retained Earnings 281.0m / Total Assets 3.14b) |
| C: 0.19 (EBIT TTM 538.0m / Avg Total Assets 2.89b) |
| D: 2.20 (Book Value of Equity 2.16b / Total Liabilities 980.0m) |
| Altman-Z'' = 5.78 = AAA |
| DSRI: 1.09 (Receivables 771.0m/633.0m, Revenue 3.99b/3.56b) |
| GMI: 1.01 (GM 34.67% / 34.49%) |
| AQI: 0.89 (AQ_t 0.17 / AQ_t-1 0.20) |
| SGI: 1.12 (Revenue 3.99b / 3.56b) |
| TATA: 0.01 (NI 359.0m - CFO 327.0m) / TA 3.14b) |
| Beneish M = -2.93 (Cap -4..+1) = A |
As of November 14, 2026, the stock is trading at EUR 44.26 with a total of 88,968 shares traded. Over the past week, the price has changed by +3.60%, over one month by -1.38%, over three months by +12.22% and over the past year by +14.69%.
Current recommended Stop Loss: 43.20 (which is 2.4% or 1.3 ATR below the current price).
Fuchs Petrolub SE has no consensus analysts rating.
P/E Trailing = 15.5912
P/E Forward = 19.084
P/S = 1.4029
P/B = 2.5945
P/EG = 4.08
Revenue TTM = 3.99b EUR
EBIT TTM = 538.0m EUR
EBITDA TTM = 638.0m EUR
Long Term Debt = 4.00m EUR (from longTermDebt, two quarters ago)
Short Term Debt = 88.0m EUR (from shortTermDebt, last quarter)
Debt = 207.0m EUR (from shortLongTermDebtTotal, last quarter) + Leases 64.0m
Net Debt = 23.0m EUR (calculated: Debt 207.0m - CCE 184.0m)
Enterprise Value = 5.62b EUR (5.60b + Debt 207.0m - CCE 184.0m)
Interest Coverage Ratio = 48.91 (Ebit TTM 538.0m / Interest Expense TTM 11.0m)
EV/FCF = 26.02x (Enterprise Value 5.62b / FCF TTM 216.0m)
FCF Yield = 3.84% (FCF TTM 216.0m / Enterprise Value 5.62b)
FCF Margin = 5.41% (FCF TTM 216.0m / Revenue TTM 3.99b)
Net Margin = 9.00% (Net Income TTM 359.0m / Revenue TTM 3.99b)
Gross Margin = 34.49% ((Revenue TTM 3.99b - Cost of Revenue TTM 2.61b) / Revenue TTM)
Gross Margin QoQ = 33.30% (prev 34.61%)
Tobins Q-Ratio = 1.79 (Enterprise Value 5.62b / Total Assets 3.14b)
Interest Expense / Debt = 5.31% (Interest Expense 11.0m / Debt 207.0m)
Taxrate = 29.75% (152.0m / 511.0m)
NOPAT = 378.0m (EBIT 538.0m * (1 - 29.75%))
Current Ratio = 2.09 (Total Current Assets 1.77b / Total Current Liabilities 847.0m)
Debt / Equity = 0.10 (Debt 207.0m / totalStockholderEquity, last quarter 2.16b)
Debt / EBITDA = 0.04 (Net Debt 23.0m / EBITDA 638.0m)
Debt / FCF = 0.11 (Net Debt 23.0m / FCF TTM 216.0m)
Total Stockholder Equity = 2.07b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.42% (Net Income 359.0m / Total Assets 3.14b)
RoE = 17.37% (Net Income TTM 359.0m / Total Stockholder Equity 2.07b)
RoCE = 25.98% (EBIT 538.0m / Capital Employed (Equity 2.07b + L.T.Debt 4.00m))
RoIC = 17.20% (NOPAT 378.0m / Invested Capital 2.20b)
WACC = 6.57% (E(5.60b)/V(5.80b) * Re(6.67%) + D(207.0m)/V(5.80b) * Rd(5.31%) * (1-Tc(0.30)))
Discount Rate = 6.67% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -59.76 | Cagr: -0.11%
[DCF] Terminal Value 73.10% ; FCFF base≈260.0m ; Y1≈228.0m ; Y5≈184.2m
[DCF] Fair Price = 44.79 (EV 2.96b - Net Debt 23.0m = Equity 2.93b / Shares 65.5m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 88.25 | EPS CAGR: 7.89% | SUE: 1.23 | # QB: 1
Revenue Correlation: 74.67 | Revenue CAGR: 3.25% | SUE: 0.0 | # QB: 0
EPS current Year (2026-12-31): EPS=2.73 | Chg30d=+7.18% | Revisions=+40% | GrowthEPS=+16.6% | GrowthRev=+15.8%
EPS next Year (2027-12-31): EPS=2.72 | Chg30d=+1.56% | Revisions=+17% | GrowthEPS=-0.5% | GrowthRev=-0.2%
[Analyst] Revisions Ratio: +38% (up=4, down=1)